Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


Evidence-base medicine: is combination of clopidogrel and proton pump inhibitors safe?

  • In: Hospital Pharmacy Posters
  • At: Lisbon (Portugal) (2010)
  • Type: Poster
  • Poster code: HPS-P-018
  • By: SYU, Fei-Kai (Fooyin Univ. Hosp. Taiwan, China & Johns Hopkins Bloomberg Sch. of Public Health, Baltimore, United States of America)
  • Co-author(s): Lai, Sow-Fei (Paochien Medical Care Paochien Hospital, PINGTUNG, China Taiwan)
    Huang, Yu-Yao (Paochien Medical Care Paochien Hospital, PINGTUNG, China Taiwan)
    Liu, Keh-Ren (Paochien Medical Care Paochien Hospital, PINGTUNG, China Taiwan)
    Lin, Chien-Liang (Fooyin University Hospital, PINGTUNG, China Taiwan)
  • Abstract:

    Background: Regarding the potential interaction of Proton Pump Inhibitors (PPIs) with Plavix® (Clopidogrel), this potential interaction could lead to a reduction in the level of Clopidogrel's active metabolite and therefore, it is what we are eager to figure out its influences.

    Method:

    Using evidence-based medicine, 822 inpatients with single..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses